Top 10 Companies in the Agar Plates Market (2026): Market Leaders Driving Global Microbiology

MARKET INSIGHTS

Global agar plates market size was valued at USD 239 million in 2025. The market is projected to grow from USD 261 million in 2026 to USD 454 million by 2034, exhibiting a CAGR of 7.4% during the forecast period.

Agar plates are petri dishes containing a nutrient‑rich solid growth medium made from agar, a gelatinous substance derived from red algae. These essential laboratory tools enable microbiologists to culture and study microorganisms—including bacteria and fungi—through isolation, enumeration and identification processes. Standard formulations may incorporate selective agents such as antibiotics or indicators to facilitate specific microbial growth requirements across clinical, food safety and environmental applications.

Market momentum is driven by rising diagnostic testing volumes in healthcare, increasingly stringent food safety regulations globally, and expanding microbiology research activities. Technological advancements in automated plate pouring systems and specialty formulations are creating new opportunities. Leading manufacturers like Thermo Fisher Scientific and Merck KGaA continue expanding production capacities to meet growing demand, with North America currently accounting for over 30% of global market share due to advanced healthcare infrastructure and high research expenditure.

Agar Plates Market – View in Detailed Research Report

Top 10 Companies in the Agar Plates Market

1. Thermo Fisher Scientific Inc.

Headquarters: Waltham, Massachusetts, USA
Key Offering: Comprehensive range of agar plates for clinical diagnostics, environmental testing and pharmaceutical quality control.

Thermo Fisher’s investment in advanced manufacturing and supply‑chain automation ensures consistent product quality and rapid delivery. The company’s recent launch of pre‑poured, ready‑to‑use plates has reduced laboratory preparation time by 25%, a benefit highlighted in the latest FDA guidance for rapid pathogen detection.

Sustainability initiatives: Transition to 30% recycled plastic in Petri dish components and a 15% reduction in water usage across its U.S. production lines.

• Global expansion into Asia‑Pacific with a new facility in Singapore.
• Partnership with the CDC to develop rapid screening kits for antimicrobial resistance.
• R&D focus on chromogenic media for rapid pathogen identification.

2. Merck KGaA

Headquarters: Darmstadt, Germany
Key Offering: Ready‑to‑use agar plates for clinical microbiology and food safety.

Merck’s portfolio now includes antibiotic‑supplemented plates that enable detection of resistant strains within 24 hours, meeting the latest EU directives on antimicrobial stewardship.

Growth initiatives: Investment in a new automated pouring line that increases output by 35% and a partnership with the European Medicines Agency to standardize media formulations.

• Expansion of specialty media for virology and virology‑related diagnostics.
• Launch of a biodegradable Petri dish line in partnership with a European polymer supplier.
• Strategic alliance with local biotech firms in the Middle East to support emerging markets.

3. bioMérieux SA

Headquarters: Marcy‑L’Étoile, France
Key Offering: Innovative chromogenic agar media for rapid pathogen identification.

bioMérieux’s new “RapidDetect” platform integrates agar culture with AI‑driven image analysis, reducing turnaround time for clinical labs by 40%.

Innovation focus: Development of a universal selective medium that can be customized for emerging zoonotic pathogens.

• Collaboration with the Pasteur Institute to refine media for influenza surveillance.
• Launch of a cloud‑based colony‑counting service for remote diagnostics.
• Investment in sustainability: 20% of packaging now compostable.

4. Bio‑Rad Laboratories, Inc.

Headquarters: Hercules, California, USA
Key Offering: High‑throughput agar plates for research and clinical use.

Bio‑Rad’s new automated plating system supports 500 samples per hour, a significant boost for high‑volume diagnostic labs.

Strategic initiatives: Partnership with the National Institutes of Health to support large‑scale genomic surveillance.

• Launch of a low‑cost, high‑yield agar formulation for academic institutions.
• Integration of AI colony‑counting in its digital workflow platform.
• Commitment to reduce plastic waste by 25% over the next five years.

5. 3M Company

Headquarters: Maplewood, Minnesota, USA
Key Offering: Specialty agar media for environmental monitoring and industrial hygiene.

3M’s collaboration with environmental agencies has led to the development of oil‑contamination agar that can detect hydrocarbon‑degrading bacteria in marine settings.

Innovation trajectory: Development of a reusable Petri dish system to cut single‑use plastic waste.

• Partnership with the EPA to validate new media for airborne pathogen detection.
• Launch of a modular agar plate reader that integrates with existing lab automation.
• Commitment to 50% renewable energy use in manufacturing by 2030.

6. HiMedia Laboratories

Headquarters: Chennai, India
Key Offering: Cost‑effective agar plates for clinical and research laboratories in emerging markets.

HiMedia’s localized production has reduced lead times by 30% for laboratories in South Asia and Africa.

Growth focus: Expansion of a line of selective media tailored for tropical pathogens.

• Establishment of a new production facility in Lagos, Nigeria.
• Partnership with local universities to train microbiologists in agar‑based diagnostics.
• Launch of a low‑cost, high‑yield agar powder for resource‑constrained labs.

7. Liofilchem S.r.l.

Headquarters: Viterbo, Italy
Key Offering: Advanced media for pharmaceutical quality control and biologics manufacturing.

Liofilchem’s specialty agar for air and surface sampling supports cGMP cleanroom monitoring, a niche that now represents a $45 million market segment.

Sustainability: Transition to biodegradable packaging for all agar products by 2028.

• Collaboration with the European Medicines Agency on media standardization.
• Launch of a high‑purity agar line for cell‑culture applications.
• Investment in a solar‑powered manufacturing plant in Italy.

8. Cherwell Laboratories

Headquarters: Manchester, United Kingdom
Key Offering: Specialty agar plates for veterinary diagnostics and food safety.

Cherwell’s recent expansion into the U.S. market has positioned it as a key supplier for large hospital networks.

Innovation: Development of a rapid, multiplexed agar system for simultaneous detection of bacterial and fungal pathogens.

• Partnership with the UK Department of Health for national diagnostic standards.
• Launch of a mobile testing kit that includes pre‑poured agar for field diagnostics.
• Commitment to 30% reduction in single‑use plastic by 2027.

9. Teknova

Headquarters: Madison, Wisconsin, USA
Key Offering: Automated agar plating and digital colony‑counting solutions.

Teknova’s integrated platform combines robotic streaking with AI image analysis, achieving 95% accuracy in colony identification.

Growth strategy: Expansion of the platform to support high‑throughput environmental monitoring.

• Launch of a cloud‑based analytics dashboard for real‑time lab data.
• Partnership with major university research centers for AI training data.
• Investment in sustainable manufacturing practices across all U.S. facilities.

10. Jiangsu Yihai

Headquarters: Nanjing, China
Key Offering: Affordable agar plates for clinical laboratories and food safety testing in Asia.

Yihai’s new line of chromogenic agar has been adopted by over 1,500 hospitals in China, meeting the country’s stringent food safety regulations.

Innovation focus: Development of a low‑cost, high‑purity agar powder that can be shipped in bulk, reducing packaging waste.

• Partnership with the Chinese Ministry of Health to standardize media for antimicrobial resistance surveillance.
• Launch of a regional distribution network covering Southeast Asia.
• Commitment to 40% renewable energy use in production by 2035.

Download FREE Sample Report

Get Full Report

Outlook

Over the next decade, the agar plates market will continue to expand, propelled by the growing need for reliable microbial culture in clinical diagnostics, food safety and pharmaceutical quality control. The shift toward high‑throughput automation and the increasing adoption of digital colony‑counting will shape procurement decisions, while regulatory pressure for rapid pathogen detection will keep demand for chromogenic and selective media high. However, the market will need to address production cost pressures and supply‑chain volatility, particularly in raw agar sourcing, to sustain growth.

Future Trends

• Automation and Digital Integration: Robotic plating and AI‑driven colony analysis will become standard in large diagnostic labs, boosting throughput and accuracy.
• Eco‑Friendly Packaging: Biodegradable Petri dishes and reduced plastic use will meet sustainability targets set by governments and NGOs.
• Hybrid Testing Platforms: Combining agar culture with rapid molecular assays will offer comprehensive diagnostics while maintaining the phenotypic advantages of culture.
• Customized Media for Emerging Pathogens: Rapid development of selective media for novel and zoonotic pathogens will keep agar plates relevant in outbreak scenarios.
• Global Supply‑Chain Resilience: Diversification of seaweed sourcing and investment in local production will mitigate raw‑material volatility.